Država: Europska Unija
Jezik: hrvatski
Izvor: EMA (European Medicines Agency)
Istradefylline
Kyowa Kirin Holdings B.V.
N04
istradefylline
Antiparkinsonski lijekovi
Parkinsonova bolest
Istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with Parkinson’s disease (PD) experiencing “OFF” time.
odbijen